The Rising Threat of Schmallenberg Virus Calls for Effective Treatment Options
The Schmallenberg virus treatment market has been driven by the increasing incidence of the Schmallenberg virus among cattle. Effective treatment and prevention of the Schmallenberg virus is crucial as it can cause abortions, stillbirths, and malformations in cattle and sheep. The virus poses a serious threat to the health of livestock and animal welfare. The market offers various vaccines and anti-viral drugs to treat and prevent SB virus infection in cattle.
The Schmallenberg virus treatment landscape comprises vaccines, antiviral drugs, and other supporting care therapies. Vaccines help activate the bovine's immune system against SB virus infection and spread. Antiviral drugs work by blocking the virus replication inside the host cell. They help control clinical signs and reduce virus shedding. The growing incidence of SB viral disease worldwide has boosted the demand for reliable treatment solutions from animal owners and farmers.
The global Schmallenberg virus treatment market is valued at US$ 110 million in 2023 and is expected to reach US$ 193.8 million by 2030, growing at a compound annual growth rate (CAGR) of 8.4% from 2023 to 2030.
Key Takeaways
Key players operating in the Schmallenberg Virus Treatment market are ASSURANT INC., American International Group, Inc., AXA, AmTrust Financial, Asurion, CARCHEX, CarShield LLC, Endurance Warranty Services LLC, Edel Assurance, SquareTrade, Inc., and Others.
The rising incidence of Schmallenberg Virus Treatment Market Trends viral infection in cattle is fueling the demand for effective treatment and prevention options. As per estimates, SB viral disease has spread across Europe, Asia, Africa, and South America. This growing threat is propelling market growth.
Get More Insights on- Schmallenberg Virus Treatment Market
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian